[1]
“Inflammatory biomarkers in the prediction of residual cardiovascular risk in patients with metabolic syndrome: An integrative literature review”, RSD, vol. 14, no. 10, p. e17141049582, Oct. 2025, doi: 10.33448/rsd-v14i10.49582.